Quality rating of the MRT of the neurocranium before a prophylactic cranial irradiation (PCI) in patients with SCLC, Limited Disease, in complete remission

被引：0
|
作者：
Manapow, F. [1 ]
Klautke, G. [1 ]
Fietkau, R. [1 ]
机构：
[1] Univ Strahlentherapie, Rostock, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [41] Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study
    Yu Chen
    Yao Wang
    Fei Ren
    Zhaoqin Huang
    Bingxu Tan
    Zhonghua Zhao
    Xinshuang Yu
    Peng Dong
    Jinming Yu
    Xiangjiao Meng
    Respiratory Research, 23
  • [42] Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study
    Chen, Yu
    Wang, Yao
    Ren, Fei
    Huang, Zhaoqin
    Tan, Bingxu
    Zhao, Zhonghua
    Yu, Xinshuang
    Dong, Peng
    Yu, Jinming
    Meng, Xiangjiao
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [43] In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
    Lukas Käsmann
    Chukwuka Eze
    Julian Taugner
    Farkhad Manapov
    Radiation Oncology, 15
  • [44] In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
    Kaesmann, Lukas
    Eze, Chukwuka
    Taugner, Julian
    Manapov, Farkhad
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [45] Prophylactic Cranial Irradiation (PCI) vs. Active Surveillance in Patients with Limited-Stage Small Cell Lung Cancer: A Retrospective, Multicenter study
    Chen, Y.
    Wang, Y.
    Ren, F.
    Huang, Z.
    Tan, B.
    Zhao, Z.
    Yu, X.
    Dong, P.
    Yu, J.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S164 - S165
  • [46] HYPERFRACTIONATED RADIOTHERAPY AND PROPHYLACTIC CRANIAL IRRADIATION IN THE ROUTINE TREATMENT OF PATIENTS WITH LIMITED-DISEASE SMALL-CELL LUNG CANCER
    Wzietek, Iwona
    Bialas, Marcin
    Gawkowska-Suwinska, Marzena
    Nowara, Elzbieta
    Suwinski, Rafal
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1340 - S1341
  • [47] NEURO-COGNITIVE FOLLOW-UP AND QUALITY OF LIFE IN PATIENTS WITH LIMITED SMALL CELL CANCER TREATED WITH TWO DIFFERENT DOSES OF PROPHYLACTIC CRANIAL IRRADIATION IN A PCI INTERGROUP RANDOMIZED TRIAL (PCI99-01, EORTC 22003-08004, RTOG 0212, IFCT 99-01) ON BEHALF OF THE PROPHYLACTIC CRANIAL IRRADIATION (PCI) COLLABORATIVE GROUP
    Le Pechoux, C.
    Laplanche, A.
    Faivre-Finn, C.
    Ciuleanu, T.
    Wanders, R.
    Lerouge, D.
    Videtic, G.
    Senan, S.
    Wolfson, A.
    Jones, R.
    Arriagada, R.
    Quoix, E.
    Dunant, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S166 - S166
  • [48] Concurrent twice daily low-dose chest radiotherapy (IFRT) and prophylactic cranial irradiation (PCI) followed by chemotherapy (CT) in limited-stage small cell lung cancer (LD SCLC)
    Vees, H
    Mach, N
    Hügli, A
    Majno, SB
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 93 - 93
  • [49] Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study
    Chen, Mengyuan
    Li, Runhua
    Kong, Yue
    Shi, Lei
    Wang, Jing
    Wang, Yuezhen
    Xu, Yujin
    Ji, Yongling
    Hu, Xiao
    BMC CANCER, 2024, 24 (01)
  • [50] Is prophylactic cranial irradiation (PCI) needed in patients with extensive-stage small cell lung cancer showing complete response to first-line chemotherapy?
    Nosaki, Kaname
    Seto, Takashi
    Shimokawa, Mototsugu
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (03) : 344 - 348
12345